Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

748 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Statin Use and Knee Osteoarthritis Outcomes: A Longitudinal Cohort Study.
Veronese N, Koyanagi A, Stubbs B, Cooper C, Guglielmi G, Rizzoli R, Schofield P, Punzi L, Al-Daghri N, Smith L, Maggi S, Reginster JY. Veronese N, et al. Among authors: rizzoli r. Arthritis Care Res (Hoboken). 2019 Aug;71(8):1052-1058. doi: 10.1002/acr.23735. Epub 2019 Jul 8. Arthritis Care Res (Hoboken). 2019. PMID: 30144308 Free PMC article.
Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
Reginster JY, Felsenberg D, Boonen S, Diez-Perez A, Rizzoli R, Brandi ML, Spector TD, Brixen K, Goemaere S, Cormier C, Balogh A, Delmas PD, Meunier PJ. Reginster JY, et al. Among authors: rizzoli r. Arthritis Rheum. 2008 Jun;58(6):1687-95. doi: 10.1002/art.23461. Arthritis Rheum. 2008. PMID: 18512789 Free article. Clinical Trial.
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
Reid DM, Devogelaer JP, Saag K, Roux C, Lau CS, Reginster JY, Papanastasiou P, Ferreira A, Hartl F, Fashola T, Mesenbrink P, Sambrook PN; HORIZON investigators. Reid DM, et al. Lancet. 2009 Apr 11;373(9671):1253-63. doi: 10.1016/S0140-6736(09)60250-6. Lancet. 2009. PMID: 19362675 Clinical Trial.
Adverse drug reactions to osteoporosis treatments.
Rizzoli R, Reginster JY. Rizzoli R, et al. Expert Rev Clin Pharmacol. 2011 Sep;4(5):593-604. doi: 10.1586/ecp.11.42. Expert Rev Clin Pharmacol. 2011. PMID: 22220306 Review.
Cutaneous side effects of antiosteoporosis treatments.
Musette P, Kaufman JM, Rizzoli R, Cacoub P, Brandi ML, Reginster JY. Musette P, et al. Among authors: rizzoli r. Ther Adv Musculoskelet Dis. 2011 Feb;3(1):31-41. doi: 10.1177/1759720X10387202. Ther Adv Musculoskelet Dis. 2011. PMID: 22870464 Free PMC article.
Fracture risk and zoledronic acid therapy in men with osteoporosis.
Boonen S, Reginster JY, Kaufman JM, Lippuner K, Zanchetta J, Langdahl B, Rizzoli R, Lipschitz S, Dimai HP, Witvrouw R, Eriksen E, Brixen K, Russo L, Claessens F, Papanastasiou P, Antunez O, Su G, Bucci-Rechtweg C, Hruska J, Incera E, Vanderschueren D, Orwoll E. Boonen S, et al. Among authors: rizzoli r. N Engl J Med. 2012 Nov 1;367(18):1714-23. doi: 10.1056/NEJMoa1204061. N Engl J Med. 2012. PMID: 23113482 Free article. Clinical Trial.
How to define responders in osteoarthritis.
Cooper C, Adachi JD, Bardin T, Berenbaum F, Flamion B, Jonsson H, Kanis JA, Pelousse F, Lems WF, Pelletier JP, Martel-Pelletier J, Reiter S, Reginster JY, Rizzoli R, Bruyère O. Cooper C, et al. Among authors: rizzoli r. Curr Med Res Opin. 2013 Jun;29(6):719-29. doi: 10.1185/03007995.2013.792793. Epub 2013 Apr 17. Curr Med Res Opin. 2013. PMID: 23557069 Free PMC article. Review.
748 results